Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Fit4MedRob grant n PNC0000007 | Other Grant/Funding Number | Fit4MedRob Foundation |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Istituti Clinici Scientifici Maugeri SpA | OTHER |
| Fondazione Don Carlo Gnocchi ETS | OTHER |
Not provided
Not provided
Not provided
Not provided
This clinical investigation aims to evaluate the safety, feasibility, and preliminary performance of the AKO-R wearable robotic device for knee assistance during walking. The study involves participants performing treadmill and overground gait training under supervised conditions, with the device providing assistive torque to support movement. Clinical and functional outcomes are assessed using validated measurement tools, while additional data are collected to characterize user performance and interaction with the device. The study is designed as an exploratory investigation to gather evidence supporting the clinical use and further development of the device. Primary outcomes regards safety of the device and preliminary clinical benefit on gait symmetry.
The study is structured in 5 sessions. The first and last session are the assessment. the 2nd session is the session for calibration of the exoskeleton parameters. The 3rd session is for exo familiarization and the 4th exo is for exo-assisted condition evaluation.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exo-Assisted | Experimental | Patients perform gait training on treadmill and overground with assistance of the investigational device |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exo-Assisted | Device | Participants perform gait training assiste by the knee exoskeletn investigational device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of device-related adverse events | through study completion, an average of 1 year | |
| Step Length Symmetry Index Change | The Step Length Symmetry Index (SI) will be compared across conditions. Descriptive data are averaged across >20 steps. Score closer to 0 means a better outcome. | Day 4 |
| Stance Time Symmetry Index Change | The Stance Time Symmetry Index (SI) will be compared across conditions. Descriptive data are averaged across >20 steps. Score closer to 0 means a better outcome. | Day 4 |
| Measure | Description | Time Frame |
|---|---|---|
| Range of motion Change | The Range of motion (computed as difference between minimum and maximum joint angle in a step) will be compared across conditions. Descriptive data are averaged across >20 steps | Day 4 |
| Self-selected velocity Change |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Don Gnocchi - Centro "S. Maria della Provvidenza" | Recruiting | Roma | RM | 00166 | Italy |
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Effect of 3 sessions on self-selected velocity, compared with Session 1. Evaluated with 10 meter walking test
| Day 5 |
| Endurance | Effect of 3 sessions on endurance, compared with Session 1. Evaluated with 2 minute walking test. | Day 5 |
| Usability score | Evaluated with System Usability Scale (SUS) questionnaire. The SUS score ranges from a minimum of 0 to a maximum of 100. | Day 5 |
| Acceptability | Evaluated with Technology Acceptance Model (TAM) questionnaire. The TAM score goes from a minimum of 0 to a maximum score of 100. | Day 5 |
| Satisfaction Score | Evaluated with Quebec User Evaluation of Satisfaction with assistive Technology 2.0 (QUEST 2.0). The QUEST goes from a minimum of 0 to a maximum of 100. | Day 5 |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |